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Introduction
Although chronic daily headache (HA) is not officially
recognised in the IHS Diagnostic Criteria [1], it is well
recognised that this group of chronic HA patients may
represent up to 40% of HA populations seeking treatment.
Many different definitions have been published for this
population (for a comprehensive review see Barton [2]).
Because of the heterogeneity in definitions of this group
of patients, research on them has lagged behind that of
IHS-defined populations such as tension-type HA and
migraine HA. For example, whereas there have been
many studies of the psychological characteristics and
degree of psychological distress among those with ten-
sion-type HA and migraine HA (for a somewhat dated
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Abstract The objective was to
investigate possible psychosocial
factors in chronic daily headache
(HA) by comparing those with
chronic daily HA to matched
patients with chronic episodic HA
and to matched non-HA controls.
Although there is some research on
psychosocial factors in chronic
daily HA, it is conflicting and none
to date has compared such patients
to both an episodic HA control and
a non-HA control. Nineteen patients
with chronic daily HA (less than
2% of 4-times-per-day HA ratings
were zero) were compared to 19
HA patients matched on age, gen-
der and nominal IHS diagnoses,
and to 16 similarly matched non-
HA controls on measures of psy-
chological distress (MMPI, BDI,
STAI), measures of life stress
(major past events, hassles,
prospective daily stress) and quality
of life (SF-36). Those with chronic
daily HA were significantly more
distressed and had significantly
poorer function on most measures
relative to non-HA controls.
Although there were many arith-
metic trends for chronic daily HA
to be more distressed and to func-
tion less well than those with
episodic HA, only on the depres-
sion and social introversion scales
of the MMPI and the overall vitali-
ty rating of the SF-36 were the dif-
ferences significant. All three
groups had comparable levels of
life stress regardless of how it was
measured. Those with chronic daily
HA have greater levels of psycho-
logical distress and poorer quality
of life than those with episodic HA
or non-HA controls, despite compa-
rable levels of life stress.
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comprehensive review see [3]; for an update see Holroyd
[4]), the literature on the psychological characteristics of
those with chronic daily HA is scant and not as method-
ologically strong.
A summary of the literature on the psychological fac-
tors and psychosocial impact of chronic daily HA is
shown in Table 1.
Psychological factors
There is a notion that chronic HA sufferers experience
more negative psychological factors than non-HA suffer-
ers. Whether such factors play a role in precipitating HA
activity or whether they are consequences of HA activity
has yet to be determined by the appropriate longitudinal
Table 1 Associated psychological and social factors in chronic daily HA groups
Chronic daily HA type/study Comparison group Psychological factors Social impact
Hart, 1985 [9] Chronic daily HA vs. episodic HA Chronic daily HA scored Not assessed
significantly higher on BDI
Mathew et al., 1987 [5] Chronic daily HA vs. episodic All chronic daily HA groups show Not assessed
migraine (EM) significant elevation on Zung and
Beck depression scales.
61% chronic daily HAs had
abnormal MMPI vs. 12.2% EM group
Solomon and Cappa, 1987 [11] None ~33% with depression, anxiety Not assessed
and/or irritability
~50% with fatigue and/or
difficulty concentrating
Blanchard et al., 1989 [7] Chronic daily high intensity No significant elevation on depression, No significant 
HA vs. HA controls anxiety or life events scales. differences
Significantly higher psychosomatic
distress vs. controls.
Significant elevations on MMPI
scales (1, 7 and 8) vs. controls but not
in clinical range (T score <70)
Solomon et al., 1992 [12] None 47% impaired concentration, 42% Not assessed
irritability, 39% depression,
36% anxiety, 35% nervousness
Cavallini et al., 1994 [14] Episodic HA (EHA) vs. During HA attack: Significantly more During HA attack:
chronic daily HA chronic daily HA report irritability, EHA more likely to 
frustration and feeling “fed up”. lie down with HA.
Interictal period: Significantly more Interictal period: 
chronic daily HA report irritability, Chronic daily HA
frustration and feeling “fed up”. more likely to
Chronic daily HA group with experience
significantly more worry about future interference in
attacks, fear of HAs getting worse, social plans and
feeling cheated out of time, feeling like family relationships
a burden to others, and feeling afraid
of letting others down
Rothrock et al., 1996 [10] Chronic tension type HA vs. EM. No differences in current/past Not assessed
New daily persistent HA + depression, stress or sleep disturbances
transformational migraine vs. EM between any groups
Chronic tension type HA vs. new
daily persistent HA +
transformational migraine
Srikiatkhachorn and None 61.7% irritability, 58.3% initial Not assessed
Phanthumchinda, 1997 [13] insomnia, 33.3% sleep fragmentation
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study. Very few studies examining chronic daily HA have
information about psychological impact and the results
have conflicted (see Table 1). For example, Mathew et al.
[5] observed that 61% of chronic daily HA sufferers had
abnormal MMPI profiles as compared to 12.2% of the
episodic migraine group. Fifty-six percent showed eleva-
tions on scales 1, 2 and 3 (the chronic illness triad). This
is in line with Burg’s [6] notion that chronic intractable
HA sufferers may have some variant of a somatoform dis-
order. While Blanchard et al. [7] observed significant dif-
ferences on three MMPI subscale scores (scales 3 –
Hysteria, 7 – Psychasthenia, and 8 – Schizophrenia)
between a chronic daily high intensity HA group and non-
daily HA controls, these group differences were small
and elevations on the subscales were not in the clinical
range (thus not “abnormal”). No other studies of chronic
daily HA have implemented the MMPI. Mathew et al. [5]
also noted that the transformational migraine group
scored significantly higher than the episodic HA control
group on a measure of Type A behaviour.
Mathew et al. [5] found that, as a group, chronic daily
HA sufferers scored significantly higher than episodic
HA patients on depression indices (Zung and Beck
Depression Inventory [8] [BDI]) and that these scores
were in the clinical range. Depression scores for all three
subtypes of chronic daily HA (chronic tension type HA,
new daily persistent HA and transformational migraine)
were significantly higher than controls. Hart [9] observed
that chronic HA sufferers scored significantly higher on
the BDI than did episodic tension sufferers. Conversely,
Blanchard et al. [7] found no differences between their
chronic daily high intensity HA group and non-daily HA
controls on measures of depression, anxiety or life
events. Similarly, Rothrock et al. [10] did not observe any
differences in depression or stress indices between chron-
ic daily HA versus non-daily HA sufferers. However,
Blanchard et al. [7] did observe significantly higher lev-
els of psychosomatic distress relative to controls. They
concluded that their chronic daily high intensity HA
group may be more psychologically distressed yet not
experience greater psychopathology than episodic HA
controls. Several other studies [11–13] report that psy-
chological symptoms, such as irritability, impaired con-
centration, depression and anxiety, are present in a large
number of chronic daily HA samples. However, these
studies did not use standardised measures of these psy-
chological symptoms and had no control groups, so the
meaning of these findings is difficult to ascertain.
Using an episodic HA control group, Cavallini et al.
[14] observed that chronic daily HA sufferers experienced
significantly higher levels of emotional disturbance during
HA attacks, with higher percentages endorsing irritability,
frustration and feeling fed up. Similarly, chronic daily HA
sufferers experienced more negative emotions during the
interictal period, relative to the episodic group. In addition
to frustration, irritability and feeling fed up, they were
more likely to feel like a burden to others, feel like they let
others down, and were more likely to worry about others
worrying about them. Further, chronic daily HA sufferers
had significantly more negative health perceptions, includ-
ing fear that their HA problem would become worse and
feeling cheated out of time. This study suggests that while
few difference in psychological distress may exist between
HA groups during HA attacks, chronic daily HA sufferers
may be significantly more distressed than those with
episodic HA between HA attacks. In summary, it seems
that chronic daily HA sufferers experience more psycho-
logical distress relative to non-daily HA sufferers.
However, strong conclusions about psychopathology
among chronic daily HA sufferers cannot yet be drawn,
given the few studies that examine this and the conflicting
findings.
Some research suggests that there may be more psy-
chopathology in chronic daily HA patients who are
intractable to treatment. Mathew et al. [15] observed sig-
nificant “behavioural abnormalities” in the 31% of chron-
ic daily HA patients who showed no improvement in HA
activity over a 42-month follow-up period as compared to
those who did improve. All (100%) had abnormal MMPI
profiles. Fifty-eight percent reported alcoholism among
their parents and 52% reported a history of physical/sexu-
al/emotional abuse. More research is needed to clarify
whether chronic daily HA patients who are psychological-
ly distressed are less likely to respond to treatment intend-
ed to suppress HA or whether non responders are a more
psychologically distressed group.
Sleep disturbance is common among chronic daily HA
sufferers. Between 58% and 71% report difficulties with
sleep [5, 13]. This is interesting, as sleep disturbance has
been noted as an aggravating factor for HAs [12, 13].
Rothrock et al. [10] observed that 57% of chronic daily
HA sufferers experienced insomnia; however, they did not
observe any significant differences in sleep disturbance
between chronic daily HA patients as compared to those
with episodic HAs. Thus, sleep disturbance may be com-
mon among HA sufferers in general.
Social impact and quality of life
Quality of life (QOL) involves many aspects of an individ-
ual’s functioning. Frequently included in assessments of
QOL are ratings of physical functioning, role functioning,
social functioning, mental health and health perceptions.
Blanchard et al. [7] examined the social impact of HAs
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among a chronic daily HA sample. No differences in social
functioning (i.e., leaving work, lying down, forgoing activi-
ties) were observed between their chronic daily high inten-
sity HA group as compared to a non-daily HA group.
Similarly, Cavallini et al. [14] observed no differences in
role functioning or social functioning during HA attacks
between an episodic HA group and a chronic daily HA
group. However, both groups showed high levels of inter-
ference. For instance, over 90% in both groups reported that
HAs made it difficult to carry on normal daily activities,
over 65% reported interference with work and over 50%
reported interference with social activities. Chronic daily
HA patients showed significantly more impairment in QOL
measures for the interictal period (between HA attacks).
Specifically, they were more likely to worry about the
occurrence of HA attacks and were more likely to experi-
ence interference with planning social activities and in fam-
ily relationships due to this worry of experiencing HAs. In
addition, mental health was also more compromised in the
chronic daily HA group (see previous section), which should
be taken into consideration when assessing QOL. The
Cavallini et al. [14] research highlights the importance of
how quality of life is measured. While chronic daily HA suf-
ferers do not significantly differ from other HA groups dur-
ing HA attacks, their QOL is markedly different in the peri-
ods between HA attacks. What is lacking from this research
is an indication of the degree of interference experienced in
each of the QOL domains. Regarding occupational func-
tioning, 20% of intractable chronic daily HA patients (those
who showed no improvement at 42-month follow up)
reported being unable to work and the rest were unproduc-
tive and had high rates of absenteeism [15]. Thus, in more
severe chronic daily HA cases, more impairment in func-
tioning may be present.
Other studies with chronic daily HA samples have not
assessed QOL. Future research with this group of HA suf-
ferers should employ QOL measures to further clarify the
impact that this HA problem can have on individuals. Given
the chronicity of chronic daily HA, the tendency to strike in
the early, productive years of life (20s–30s), and its
intractable nature, it is likely that QOL is compromised
among this group.
Summarising the material above and the studies in Table
1, it is clear that no study has compared chronic daily HA to
both episodic HA and non-HA controls in the same study.
Moreover, only 3 studies [5, 7, 9] have used well validated
psychological tests and the results of these studies are in
conflict. Finally, the two studies [7, 14] that examined the
psychosocial impact, or QOL, of chronic daily HA did not
use standardised measures. Moreover, the results of the two
studies were contradictory.
This high level of inconsistency in results and use of
poor quality measures has led to the present study that
sought to compare a sample with chronic daily HA to a
sample, matched on age, gender and nominal IHS diagno-
sis, of individuals suffering from episodic HA, and very
importantly, to a sample of non-HA sufferers also matched
for gender and age, using well validated measures of both
psychological distress and QOL.
Methods
Overview
All participants in this research were drawn from a larger
assessment study examining the interrelations of HA, daily
stressful events, mood and HA medication consumption.
Participants monitored HA, perceived stress and mood four
times per day with handheld computers and recorded HA med-
ication consumption daily for 6 weeks. They were paid $120 for
their successful completion of the monitoring. Non-HA controls
completed the same monitoring for 6 weeks and were paid $150.
All gave informed consent.
Participants
Chronic daily HA
Nineteen individuals who met our somewhat liberal definition of
chronic daily HA, no more than one HA-free day per week, were
used. In fact, there were only 12 out of 672 days (1.8%) on which
no HA occurred in this sample.
Episodic HA
These 19 individuals were selected from the larger sample to match
the chronic daily HA sample on nominal IHS diagnosis, gender and
age within 4 years.
Non-HA
These 16 individuals at a telephone screen claimed not to be both-
ered by HAs and to suffer no more than one mild HA per month.
They were also selected to match the chronic daily HA population
on gender and age within 4 years.
Demographic characteristics of the 3 samples, as well as distri-
bution of nominal IHS diagnoses are in Table 2. The only differ-
ence among the groups was on education level with slightly over
80% of the HA control and non-HA control participants being col-
lege graduates (Associates degree or higher) versus only 47% of
those with chronic daily HA (χ2[2, n=54]=7.41, p<0.01, effect
size=0.37).
Procedures
All HA sufferers underwent an extensive structured interview [16]
to arrive at an IHS HA diagnosis and gather extensive information
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on the background of their HA problem. A detailed psychosocial
history and mental status examination were also performed.
Individuals with a diagnosis of current major depression, or alco-
hol or substance dependence were excluded, as were individuals
with a history of schizophrenia or other psychotic disorder or bipo-
lar disorder. Also excluded were individuals whose HAs began fol-
lowing a physical trauma or whiplash injury.
As part of the larger research study, participants were instruct-
ed in the use of a handheld computer [17] with which they moni-
tored levels of HA, perceived stress and mood 4 times per day at
approximately meal times and bedtime. HA ratings ranged from 0
(no HA) to 5 (intense incapacitating HA) on a scale that has been
shown to be reliable [18]. They also recorded all medications taken
for their HA on a daily basis and filled out the Daily Stress
Inventory on a daily basis.
The Daily Stress Inventory [19] consists of a list of 58 poten-
tially stressful events that are scored from 1 (occurred but was not
stressful) to 7 (caused me to panic). The scale has well established
reliability and validity. It yields 3 scores, number of events that
occurred, intensity (sum of intensity ratings for all scored events)
and impact/event ratio (the sum of intensity ratings divided by
number of events. Participants also completed a number of stan-
dardised psychological tests measuring three broad domains, (a)
psychological distress, (b) quality of life and (c) level of life stress.
Psychological distress
We administered the BDI [8], a 21-item scale that is one of the
most widely used self-report measures of depressive symptoms
[20], and the State-Trait Anxiety Inventory [21] scored for both
current state anxiety and the overall trait of anxiety, each with 20-
item scales. It has well established reliability and validity. We also
administered the MMPI scored for the 9 clinical scales.
Quality of life
For a measure of QOL we used the SF-36 [22]. It provides scores
on 8 subscales of psychosocial functioning.
Life stress
In addition to the measure of daily stressful events described
above, the Daily Stress Inventory, participants also completed the
Hassles Scale [23], which assesses frequency and severity of 64
low-level stressful events that have occurred over the past 30 days.
Participants also completed a survey of major life events occurring
over the preceding 12 months, the Social Readjustment Rating
Scale [24].
Results
Comparisons of HA samples
The two HA samples were each comprised of 11 individ-
uals with IHS diagnoses of chronic tension-type HA and 8
individuals with IHS diagnoses of both tension-type HA
and migraine HA without aura. Comparisons on HA diary
data revealed significant differences in HA index (the
daily average sum of the 4 HA ratings) (chronic daily HA
– 9.2, HA control – 4.5, t[36]=5.07, p<0.001, effect size
1.61) and percent of HA free days (chronic daily HA –
1.8%, HA control=30.1%), t[36]=3.68, p<0.001, effect
size 1.12). On medication index the two groups did not
differ (chronic daily HA – 38.2, HA control – 28.7,
t[36]=0.70, effect size=0.22).
Table 2 Demographic and HA variables of chronic daily HA, HA control and non-HA control groups
Measure Chronic daily HA control Non-HA control Statistical test Effect sizea
HA (n=19) (n=19) (n=16)
Age 36.3 42.1 36.4 F=1.13**
Gender, % female 63.2 63.2 62.5 χ2=0.002** 0.006
Family income, US dollars 51 900 62 700 60 200 F=0.45**
Ethnicity, % Caucasian 100 100 100
Education, % college graduate 47.4 84.2 81.3 χ2=7.41** 0.37
Childhood physical and/or sexual abuse, % 31.3 21.1 18.8 χ2=0.80** 0.67
Family history of alcohol/substance abuse, % 31.3 21.1 18.8 χ2=0.80** 0.67
HA index 9.15 4.49 t=5.07** 1.61
HA free days, % 1.80 30.1 t=-3.68** 1.12
Medication score 38.2 28.7 t=-0.70** 0.22
HA diagnosis
Tension-type 11 11
Tension-type+migraine without aura 8 8
aFor t-tests, effect size used was d statistic; for chi-square tests, effect size used was Phi coefficient, *p<0.01, **p<0.001
HA index, average daily HA score for the baseline period; % HA free days, percentage of days with no HA during the baseline period; med-
ication score, average weekly medication score for the baseline period
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Thus, the chronic daily HA group had HA almost all of
the time at a moderate to severe level; however, their anal-
gesic medication consumption was only moderate and
below the levels we have seen for “rebound HA” [25].
Primary comparisons
In Tables 3, 4 and 5 are the mean values for the three groups
on measures of psychological distress, measures of quality
of life and measures of life stress, respectively. The data in
each table were subjected to a series of one-way ANOVAs
on each measure. When the overall F test was significant,
follow-up comparisons using the very conservative Tukey’s
HSD test were performed at the 0.05 level. In order to give
a clear sense of differences between pairs of groups, the
effect size for the pairwise comparison and the percent of
the chronic daily HA sample scoring above the mean of the
comparison sample, either episodic HA control or non-HA
control, is presented.
Psychological distress
There were significant between-group differences on 10 of
the 12 psychological distress measures with only scales PD
and MA of the MMPI not yielding significance. The chron-
ic daily HA group was significantly more distressed than the
non-HA control group on all of the significant measures
with 80% or more of the HA group’s scores falling above the
mean of the control group.
On the more important comparisons between chronic
daily HA and episodic HA, there were only two differences
which reached significance using the conservative Tukey
HSD test, scale D (depression) of the MMPI and scale SI
(social introversion). On all of the other measures, there were
arithmetic differences between the two HA groups but the dif-
ferences did not reach the stringent level used in the analyses.
Quality of life
On 7 of the 8 subscales of the SF-36, there were significant
differences among the three groups; the sole exception was
Table 3 Values for psychological distress measures for three groups
Variable Experimental groups Overall Chronic daily Chronic daily HA
comparison HA vs. HA vs. non-HA
control control
Chronic daily HA HA control Non-HA control
M SD M SD M SD F p Effect Percent Effect Percent 
size d of chronic size d of chronic
daily HA daily HA
above mean above
(below mean) mean




BDI 10.4a 5.7 8.1aa, 5.1 2.9b 3.2 10.4 <0.001 0.42 66.2 1.60 94.5
STAI-State 42.4a 10.2 37.9aa, 10.9 27.6b 6.1 11.1 <0.001 0.42 66.2 1.70 95.5
STAI-Trait 44.4a 10.9 38.0a,b 11.0 33.0b 5.1 6.27 0.004 0.57 71.5 1.30 90.3
MMPI
HS 70.5a 13.5 68.2aa, 10.3 51.0b 8.0 15.9 <0.001 0.19 57.5 1.69 95.4
D 75.2a 12.9 63.4ba, 11.1 55.1b 8.7 14.3 <0.001 0.95 82.8 1.74 95.4
HY 70.5a 10.2 67.1aa, 9.2 56.4b 7.4 11.1 <0.001 0.34 63.3 1.51 93.4
PD 63.1a 9.0 59.9a,b 9.9 58.6a 9.0 1.09 ns 0.33 62.9 0.49 68.8
PA 62.5a 9.8 57.7a,b 8.9 54.6b 6.7 3.72 0.031 0.50 69.0 0.90 81.5
PT 66.3a 11.6 60.8a,b 9.5 54.7b 5.6 6.56 0.003 0.50 69.0 1.20 88.4
SC 64.3a 13.2 60.3a,b 10.3 54.9b 7.6 3.26 0.047 0.33 62.9 0.83 79.6
MA 51.1a 11.7 55.1a,b 12.7 56.4a 11.8 0.93 ns 0.32 (62.6) 0.44 (67.0)
SI 63.1a 12.7 51.2ba, 10.3 48.4b 9.1 9.21 <0.001 1.00 84.0 1.30 90.3
Means that share a superscript are not different at the 0.05 level by Tukey’s HSD test
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on physical functioning. As with the measures of psycho-
logical distress described above, the chronic daily HA group
was significantly lower (again by Tukey’s HSD test) than
the non-HA controls on all seven subscales. Again, 80 to
above 90% of those with chronic daily HA scored below the
mean of the control group.
When the two HA groups were compared, however, the
chronic daily HA group was significantly lower only on the
subscale measuring reported vitality. There were again arith-
metic differences for the chronic daily HA group to score
lower than the episodic HA group with noticeable discrep-
ancies on physical role performance and rating of general
health.
Measures of life stress
By way of contrast there was only a single between-group
difference on the measures of life stress that reached signif-
icance, the intensity to frequency ratio of the DSI. On this
measure, which essentially yields a measure of current life
stressor intensity corrected for how frequently stresses
occur, the two HA groups were higher than the non-HA con-
trol. Moreover, the comparison of the chronic daily HA
group to the non-HA controls shows that over 90% of the
HA sufferers are higher than the mean of the controls. The
two HA groups did not differ.
Discussion
The primary aim of this study was to clarify the psychoso-
cial functioning of chronic daily HA relative to other episod-
ic HA sufferers and relative to normal, healthy controls. This
study is the first to use both a HA and non-HA control group,
to use standardised, reliable measures of psychosocial func-
tioning, and to incorporate a measure of role functioning
impairment/quality of life. As predicted, chronic daily HA
subjects were clearly more psychologically distressed than
normal healthy matched subjects. Indices of depression,
anxiety and stress impact are elevated in the majority
(greater than 70%) of chronic daily HA sufferers relative to
Table 4 Values for quality of life measures (SF-36) for three groups
Variable Experimental groups Overall Chronic daily Chronic daily HA
comparison HA vs. HA vs. non-HA
control control
Chronic daily HA HA control Non-HA control
M SD M SD M SD F p Effect Percent Effect Percent 
size d of chronic size d of chronic
daily HA daily HA
above mean above
(below mean) mean




Physical 82.4a 18.1 89.7a,b 19.6 92.8b 14.3 1.66 ns 0.38 (64.8) 0.62 (73.2)
functioning
Role- 38.2a 39.4 61.8a,b 46.7 87.5b 28.9 6.77 0.002 0.53 (70.0) 1.38 (91.6)
physical
Bodily pain 50.6a 22.2 54.5aa, 21.1 83.6b 14.6 13.9 <0.001 0.18 (57.1) 1.70 (95.5)
General 59.7a 20.0 74.2a,b 23.7 83.9b 12.3 6.76 0.002 0.65 (74.2) 1.40 (91.1)
health
Vitality 39.7a 21.9 57.1ba, 16.6 67.8b 12.6 11.3 <0.001 0.88 (81.0) 1.50 (93.3)
Social 75.6a 22.6 77.7aa, 24.8 94.6b 10.2 4.26 0.020 0.08 (53.2) 1.02 (84.6)
functioning
Role- 64.8a 39.2 78.9a,b 35.5 97.9b 8.3 4.73 0.013 0.37 (64.4) 1.10 (86.4)
emotional
Mental 64.4a 14.4 70.2a,b 17.5 78.8b 14.3 3.73 0.031 0.35 (63.7) 0.98 (83.6)
health
Means that share a superscript are not different at the 0.05 level by Tukey’s HSD test
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the average scores of normal healthy subjects. These eleva-
tions are also clinically meaningful. Mean scores for three
MMPI subscales (scales HS, D and HY) are in the clinical
range. This finding contrasts with those of Blanchard et al.
[7], in which elevations on the MMPI subscales for chronic
daily HAs were not in the clinical range (thus not “abnor-
mal”) and agrees with Mathew et al. [5]. Chronic daily HA
sufferers also score significantly higher (but not in the clin-
ical range) on scales PT and SI. Mean scores for State anxi-
ety are above the 70th percentile range and for Trait anxiety
are just above the 80th percentile rank, indicating high lev-
els of anxiety.
Very little data exist on role functioning and other
aspects of QOL among those with chronic daily HAs. As
predicted, chronic daily HA sufferers also experience much
more impairment in multiple areas of their lives as indicat-
ed by lower scores on 5 of the 8 subscales of the SF-36 rel-
ative to non-HA sufferers. Chronic daily HA sufferers are
significantly more likely to experience problems with work
or other daily activities as a result of HAs. Emotionally they
are significantly more depressed and more likely to experi-
ence interference with role functioning as a result of emo-
tional distress. They also experience more bodily pain, have
poorer evaluations of their current overall health and future
health, and feel tired most of the time. The effect sizes asso-
ciated with these findings indicate strong differences. In
fact, more than 90% of chronic daily HAs scored below the
mean (indicating poorer functioning) of healthy controls on
4 of the 5 statistically significant SF-36 subscales, and more
than 85% scored below the mean of controls on the fifth
subscale (Role-emotional).
While it seems logical that chronic daily HA sufferers
manifest more psychological distress than healthy popula-
tions, also of interest is whether chronic daily HAs may also
experience more psychosocial distress and impairment than
chronic HA sufferers. While many statistical tests were not
significant, examination of the effect sizes suggest strong
differences may exist. Future studies should recruit larger
sample sizes to test these findings. Two reliable measures of
depression (BDI, MMPI Depression scale) are elevated in
chronic daily HA sufferers relative to the episodic HA sam-
ple. On the MMPI-D scale, 82.80% of those with chronic
daily HAs score above the mean score of HA controls.
Again, the mean scores for those with chronic daily HAs on
these depression measures are in the clinical range while
mean scores for the episodic HA controls are not. Chronic
daily HA sufferers may be more socially isolated/inhibited
as indicated by the MMPI SI scale; 84% of the former score
above the mean of episodic HA controls on this scale.
Chronic daily HA sufferers may be more anxious than non-
Table 5 Values of life stress measures for three groups
Variable Experimental groups Overall Chronic daily Chronic daily HA
comparison HA vs. HA control vs. non-HA control
Chronic daily HA HA control Non-HA control
M SD M SD M SD F p Effect Percent Effect Percent 
size d of chronic size d of chronic
daily HA daily HA
above mean above
(below mean) mean








Frequency 38.4a 14.6 37.9a 21.2 30.1b 14.6 1.24 ns 0.02 50.8 0.56 71.2
Intensity 55.3a 22.2 54.5a 35.8 40.9b 23.6 1.41 ns 0.03 51.7 0.62 73.2
Daily Stress
Inventory
Frequency 54.3a 38.1 51.6a 32.4 46.4b 27.0 0.25 ns 0.07 52.8 0.33 59.1
Intensity 165.4a 128.0 142.9a 90.8 96.1b 59.2 2.19 ns 0.20 57.9 0.66 74.5
Int/Freq. 2.97a 0.60 2.74a 0.62 2.05b 0.48 11.8 <0.001 0.48 68.4 1.50 93.3
Means that share a superscript are not different at the 0.05 level by Tukey’s HSD test
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daily HA sufferers; over 70% of chronic daily HA sufferers
score above the mean of the episodic HA sufferers on trait
anxiety. Chronic daily HA sufferers may also experience
more functional impairment than chronic episodic HA suf-
ferers. SF-36 scores indicate that those with chronic daily
HA tend to have less energy, view their general health as
poorer and experience more impairment in physical activi-
ties than non-daily episodic HA sufferers. This conflicts
with previous findings [7] in which chronic daily HAs did
not suffer more impairment in role functioning than episod-
ic HA sufferers.
Thus, on a number of reliable, valid measures, those with
chronic daily HAs show poorer functioning and more dis-
tress than chronic episodic HA sufferers. Previous studies
(e.g., [7]) had shown that, while there were differences
between chronic daily HAs and HA controls, these differ-
ences were not clinically significant (i.e., test scores were
not in the clinical range). However, in this study, indices
tend to fall in the clinical range for those with chronic daily
HAs. These findings also highlight the need to consider psy-
chological outcomes in HA treatment.
No differences were found among the three groups in
levels of previous stressful events, either major life events
over the previous year, minor hassles over the previous
month, or daily stressors during the HA monitoring period.
There was a difference on the DSI measure of rated intensi-
ty per event with those suffering from chronic daily HA rat-
ing the intensity per event higher than the non-HA controls.
Previous research [5, 26, 27] has indicated that chron-
ic daily HA sufferers tend to use symptomatic medications
excessively, typically classifying 50–73% as high medica-
tors. No studies have compared medication use among
those with chronic daily HAs and chronic episodic HA
sufferers. Two interesting findings emerged in this study.
First, chronic daily HAs did not tend to use more medica-
tion than the episodic HA sufferers matched for IHS diag-
nosis, HA duration, gender and age. Second, no patient
with chronic daily HA met criteria for “excessive use” in
this study. While the criteria used were less restrictive
(i.e., required higher levels of medication to qualify as
high medicators) than some studies [26, 27] with high
rates, they were more restrictive (i.e., required lower lev-
els of medication to qualify as a high medicator) than
those used in studies [25, 26] that reported excessive use
in 12–17% of chronic daily HA sufferers.
Data from the HA interview indicated that chronic
daily HA sufferers feel HAs result in significant social
interference. A large number of chronic daily HA sufferers
reported that HAs cause them to go to bed, forgo social
activities, cause them to be less effective/slow down, and
interfere with sexual functioning. However, the amount of
interference reported was not any greater than that report-
ed by those with chronic episodic HA. Also, the familial
response to HA did not differ between the two groups.
Chronic daily HA and HA control groups reported similar
familial response (some secondary gains such as reduced
household responsibility) to HA complaints, making it
seem unlikely that chronic daily HAs had more secondary
gain issues related to their HA complaints.
There are limitations to this study, primarily in terms of
sample size. Given some of the effect sizes shown in Table
3, larger samples would probably have led to more signifi-
cant differences between those with chronic daily HA and
chronic episodic HA. Also, the sample was not explicitly
seeking treatment; instead they had volunteered for research
where treatment was a possible option. Lastly, this was a
cross-sectional study measuring participants at a single
point in their HA career. Thus we cannot tell whether having
chronic daily HA causes the increased level of psychologi-
cal distress and poorer role functioning or whether psycho-
logical characteristics (such as depression) predisposes to
developing chronic daily HA. 
Regardless, we believe we have contributed to a fuller
understanding of these very troubled HA populations.
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